Company / Cost of Revenue
Phibro Animal Health Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$896.3M
FY2025
5-year range
$562.0M / $896.3M
FY2021-FY2025
Trend
+27.2%
vs FY2024
Sector context
#18 of 85
Health Care
What the data says
Phibro Animal Health's cost of revenue of $896M is higher than 79% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 10 years, ranging from $512M in FY2018 to $896M in FY2025.
Based on SEC 10-K filings.
$896M in FY2025 with a 5-year CAGR of +10.5%. Top quartile in the Health Care sector.
Increased from $562M to $896M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +10.9%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 85This company $896.3M Sector average $2.0B
▼
-54.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 27.2% year-over-year.
- Ranks #18 out of 85 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2018.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $896.3M | +27.2% |
| FY2024 | $704.6M | +25.4% |
| FY2023 | $562.0M | -14.4% |
| FY2022 | $656.9M | +16.9% |
| FY2021 | $562.0M | +3.4% |
| FY2020 | $543.5M | -3.5% |
| FY2019 | $563.4M | +9.9% |
| FY2018 | $512.5M | -0.7% |
| FY2017 | $516.0M | +0.7% |
| FY2016 | $512.5M | +8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026